2026, Number 4
<< Back Next >>
Cir Card Mex 2026; 11 (4)
Risk factors for acute liver injury after cardiac surgery: the dominant role of surgical complexity
Hernández-Zamonsett D, Arellano-Juárez L, Lezama-Urtecho CA, Jiménez-Olmedo D, Méndez-Ríos U, Martínez-Carmona R
Language: English
References: 15
Page: 145-149
PDF size: 928.19 Kb.
ABSTRACT
Introduction: postoperative acute liver injury (ALI) is a frequent and
severe complication of cardiac surgery with cardiopulmonary bypass
(CPB), associated with high morbidity and mortality. However, the
role of surgical complexity as an independent risk factor, beyond
CPB duration, remains unclear. This study aimed to determine the
incidence of ALI, identify its independent predictors, and quantify
its impact on clinical outcomes.
Material: a retrospective cohort
study was conducted on 172 consecutive patients undergoing cardiac
surgery with CPB. ALI was defined as a binary outcome based on
peak postoperative laboratory values: (total bilirubin > 3 mg/dl)
and (AST > 100 IU/l or ALT > 100 IU/l). A multivariate logistic
regression model was used to identify ALI predictors (variables:
baseline total bilirubin [TBL], CPB time, procedure group). The
impact on outcomes (mortality, major bleeding, reoperation) was
assessed using χ2 tests and crude odds ratios (ORs).
Results: the
overall incidence of ALI was 32 (18.6%) out of 172 patients.
In the multivariate analysis, Complex procedure was the only
independent and statistically significant predictor (adjusted OR
10.06, 95%CI 2.36-42.88; p = 0.002), rendering CPB time no
longer an independent predictor (p = 0.511) and baseline TBL (p =
0.548). Patients who developed ALI exhibited complication rates
two to three times higher. A strong trend of association with major
bleeding was observed (crude OR 3.05; p = 0.089). Associations
with mortality (OR 2.52; p = 0.169) and reoperation (OR 2.76; p = 0.125) did not reach statistical significance.
Conclusions: surgical
complexity (complex procedure) is the primary determinant for
postoperative ALI, independent of CPB duration. ALI is a sentinel
event for severe morbidity, strongly associated with the risk of major
bleeding. The magnitude of the observed effect on mortality (OR >
2.5) generates a robust hypothesis that warrants prospective studies
with greater statistical power for validation.
REFERENCES
Kirklin JW. Open-heart surgery at the Mayo Clinic. The 25thanniversary. Mayo Clin Proc. 1980;55(5):339-341.
Paparella D, Yau TM, Young E. Cardiopulmonary bypass inducedinflammation: pathophysiology and treatment. Eur J CardiothoracSurg. 2002;21:232-244. doi: 10.1016/s1010-7940(01)01117-9.
Tashkandi H, Alghamdi A, Al-Radi S, et al. Acute hepatic injuryfollowing cardiac surgery: a retrospective observational study. Saudi JAnaesth. 2023;17:371-378. doi: 10.4103/sja.sja_104_23.
Salis S, Mazzanti VV, Merli G, et al. Cardiopulmonary bypassduration is an independent predictor of morbidity and mortality aftercardiac surgery. J Cardiothorac Vasc Anesth. 2008;22:814-822. doi:10.1053/j.jvca.2008.08.004.
Gomes E, Pires L, Casagrande C, et al. Cardiopulmonary bypassischemic hepatitis: report of five patients. Rev Bras Cir Cardiovasc.2016;31:359-363. doi: 10.5935/1678-9741.20160060.
Karamlou T, Shen I, Miller-Tate H, et al. Risk and prognosis of acuteliver injury among hospitalized patients with hemodynamic instability:a nationwide analysis. Ann Hepatol. 2019;18:783-790. doi: 10.1016/j.aohep.2019.06.002.
Sherlock S. The liver in heart failure. Br Heart J. 1951;13:273-293.doi: 10.1136/hrt.13.3.273.
Nath S, Ghosh S, Kar A, et al. Hepatic and renal effects ofcardiopulmonary bypass. J Anaesthesiol Clin Pharmacol. 2015;31:303-307. doi: 10.4103/0970-9185.161657.
Song Y, Kim Y, Kwak Y. Association of liver dysfunction withoutcomes after cardiac surgery: a meta-analysis. J Cardiothorac Surg.2022;17:303. doi: 10.1186/s13019-022-02058-2.
Ji F, Zhu Y, Zhang Y, et al. Prognosis and risk factors for postoperativehepatic dysfunction in acute type A aortic dissection. Ann ThoracCardiovasc Surg. 2023;29:89-97. doi: 10.5761/atcs.oa.22-00166.
Sabzi F, Faraji R. Liver function tests following open cardiac surgery.J Cardiovasc Thorac Res. 2015;7:49-54. doi: 10.15171/jcvtr.2015.11.
Nissinen J, Biancari F, Wistbacka JO, et al. Safe time limits of aorticcross-clamping and cardiopulmonary bypass in adult cardiac surgery.Perfusion. 2009;24:297-305. doi: 10.1177/0267659109354656.
Wang J, Yu W, Zhai G, et al. Risk factors for acute kidney injuryand their interaction with liver dysfunction after cardiac surgery. JCardiothorac Surg. 2021;16:333. doi: 10.1186/s13019-021-01713-4.
Ailawadi G, Lapar DJ, Swenson BR, et al. Model for end-stage liverdisease predicts mortality for tricuspid valve surgery. Ann ThoracSurg. 2009;87:1460-1468. doi: 10.1016/j.athoracsur.2009.01.043.
Karkouti K, Wijeysundera DN, Yau TM, et al. The independentassociation of massive blood loss with mortality in cardiacsurgery. Transfusion. 2004;44:1453-1462. doi: 10.1111/j.1537-2995.2004.04144.x.